Mass spectrometry has been applied to determine the deamidation sites and the aggregation region of the deamidated human islet amyloid polypeptide (hIAPP). Mutant hIAPP with iso-aspartic residue mutations at possible deamidation sites showed very different fibril formation behavior, which correlates with the observed deamidation-induced acceleration of hIAPP aggregation.
1
Deamidation occurs spontaneously in solution at asparagine (Asn) and glutamine (Gln) residues, and results in formation of iso-aspartic acid/aspartic acid and γ-glutamic acid/glutamic acid (and their stereoisomers), respectively. 2, 3 The deamidation rate of Asn is faster than Gln due to the shorter distance between the main chain amido group (-NH-) and the side chain amide group (-NH2-). 4, 5 With an additional methylene group (-CH2-) into the backbone of isoaspartic acid and γ-glutamic acid; the tertiary structure, stability, folding, and function of proteins can be dramatically altered by deamidation. 6, 7 Previous studies showed that deamidation can accelerate fibril formation in certain cases, including mutated amyloid-β (D7N and D23N) observed in Alzheimer's disease. 8, 9 Aggregation of β2-microglobulin from dialysis-associated amyloidosis disease, 10, 11 and αB-crystallin from human eye lens have also been shown to be affected by deamidation. 12, 13 Human islet amyloid polypeptide (hIAPP; also referred to as amylin) is a 37-residue hormone peptide co-secreted with insulin and involved in regulating blood glucose levels. 14 The concentration of hIAPP is around 1-2% relative to the level of insulin in secretory granules. 15 hIAPP contains an intramolecular disulfide bond between Cys-2 and Cys-7, as well as an amidated C-terminus, 16 and is an intrinsically disordered protein with a low level of persistent helical structure between residues Asn-3 and Leu-27 in solution. 17 hIAPP is an amyloid protein which contains six Asn and one Gln as potential deamidation sites. A previous study from Nilsson et al. used a variant of hIAPP segment, residues 20-29 (SNNFPAILSS) which is non-amyloidogenic and showed that addition of less than 5% of deamidated monomer could accelerate the amyloid fibril formation. 18 Results from Dunkelberger et al. also showed that deamidation of hIAPP disrupted the β-sheet structure around Leu-27, resulting in a morphology change of hIAPP fibrils, along with accelerated fibril formation. 19 The formation of hIAPP fibrils does not contribute to type II diabetes (T2D); however early oligomers of hIAPP lead to the decline of pancreatic β-cell mass and the failure of islet cell transplantation for T2D treatment. [20] [21] [22] Thus, accelerating the formation of the early oligomers of hIAPP may reduce the graft survival rate. 17, 23 Deamidation has a significant impact on hIAPP fibril formation, 24, 25 the effects on the deamidation rate, the deamidation site(s), and the effects of isomeric deamidation products of hIAPP, however, have not yet been fully addressed. MS is a powerful tool for examining deamidation in proteins as the deamidation reaction produces products with a mass shift of +0.984 Da (-NH2 to -OH) at the deamidated residue, which is readily detected by MS. [26] [27] [28] Previous studies also suggested that deamidation can be directly quantified by measuring the peak area of the non-deamidated and deamidated peaks, thus the percentage of deamidation in the sample can be estimated. 29, 30 Tandem MS/MS can further locate the deamidation site in proteins, and differentiate the isomeric deamidation products. Electron capture dissociation (ECD) MS/MS can be used to not only localises the deamidation site in protein, but also uses to differentiate the isomeric products of deamidation by the mass shift of +58 and -57 Da at the c and z ion fragments of iso-/γ-deamidation products respectively. The peak intensity of iso-/γ-deamidation products can also compare with the peak intensity of aspartic acid/glutamic acid in order to determine the ratio of the isomeric products. 29 In order to localise the deamidation site(s) in the incubated hIAPP solution, CAD MS/MS with a 12 Tesla (T) Fourier transform ion cyclotron mass spectrometer (FTICR MS) was applied. The y5 fragment clearly showed a deamidated peak in the incubated sample (Fig. 1B) , indicating deamidation occurs at Asn-35 residue in hIAPP. For the b fragments, no deamidated peaks were observed for the first 20 amino acid residues (Fig. 1C) ; however, a deamidated peak was present corresponding to the b21 fragment ( Fig. 1D) , suggesting deamidation only occurs at Asn-21 but not at Asn-3, Gln-10, and
Asn-14 residues. Furthermore, another deamidated peak was detected corresponding to the b22 fragment ion in the incubated solution ( Subsequently, MS was applied to determine the deamidation rates of each individual deamidated site in the incubated solutions and resulting fibrils by calculating the percentage ratio between the non-deamidated and the deamidated fragment ion peak areas for each sample. In the incubated solution, the earliest deamidation instance was observed on day 5, and was identified within the y5 fragment ion ( Fig. 2A) Deamidation was observed in the day-7, day-14, day-21, and day-28 samples ( Fig. 2B ).
On day-7, ~7.5% of the y5 fragment ion was deamidated while no deamidation was observed for the b21 and b22 fragment ions in the pellet. On day-14, the extent of deamidation for the y5 fragment ion increased sharply to 16% and the b21 and b22
showed ~7.5% deamidation. After 28 days incubation, the extent of deamidation of the y5, b21, and b22 fragment ions were at 39%, 30%, and 29% respectively, distinctly larger than for the soluble hIAPP species above, suggesting the fibrils of hIAPP contains a higher extent of deamidation at Asn-35 compared to Asn-21 and Asn-22 residues.
The residue Asn-35 was the earliest deamidation site observed in the incubated solutions and contained the highest extent of deamidation in the fibril pellets, which agrees with the findings in previous deamidation studies, 3, 31 suggesting that the primary sequence of Ser- 35 Asn-Thr in hIAPP had the shortest deamidation time among all the other segments studied. The higher extent of deamidation observed in the fibrils of hIAPP compared to the incubated solutions also indicates that deamidated hIAPP tends to aggregate and form insoluble fibrils more rapidly than the wild-type hIAPP. In order to ascertain the effects of deamidated isomeric products on the aggregation process, pure mutant hIAPP peptides were synthesised with aspartic acid ((D)3hIAPP) or iso-aspartic acid ((isoD)3hIAPP) replacement at the detected deamidation site from above, i.e. residues 21, 22, and 35 ( Fig. S1 , ESI †). The 7+ charge state dimers of ((D)3hIAPP) and ((isoD)3hIAPP) were fragmented by ECD MS/MS in order to determine the non-covalent interaction region between the mutant hIAPP units (Fig. S2 -S3 , ESI †). The aggregation regions of ((D)3hIAPP) and ((isoD)3hIAPP) were found between Asn-31 and Thr-36 residues, which is similar to the proposed aggregation region of 7+ charge state dimer of wild-type hIAPP in the previous studies, suggesting there is no difference between the wild-type and the two mutant hIAPPs regarding the aggregation sites for the formation of early oligomers. 32 MS can quantify soluble amyloid proteins in solution. 32 The ionisation of aqueous protein solutions to gas phase ions, however, is limited to soluble components only, so that the insoluble fibrils are difficult to quantify using MS. Thus, the relative concentration of amyloid fibrils formed in the incubated solutions were determined by using Thioflavin T (ThT) fluorescence emission analysis at the wavelength of 490 nm and the overall structures of fibrils were observed using transmission electron microscopy (TEM). The relative fluorescence emission of the 10 μM solutions of wild-type hIAPP, ((D)3hIAPP), and ((isoD)3hIAPP) were measured and the lag phases of the formation of mature fibrils in wild-type hIAPP solution was 42 hours while in ((D)3hIAPP) and ((isoD)3hIAPP) solutions were ~ 30 hours (Fig. 3A -3C ), indicating mutant hIAPPs with deamidated residues replacement at Asn-21, Asn-22, and Asn-35 accelerate the rate of mature fibrils formation which supports the hypothesis that deamidated hIAPPs accelerate the aggregation rate of non-deamidated hIAPP. 18, 19 TEM images of the wild-type hIAPP, ((D)3hIAPP), and ((isoD)3hIAPP) solutions incubated at 37 o C for one week were also obtained ( Fig. 3E -3G In order to study the effects of the isomeric deamidation products on the wild-type hIAPP aggregation, ((D)3hIAPP) and ((isoD)3hIAPP) solutions were individually spiked into wild-type hIAPP solution at 5%, 10%, 25%, and 50% amounts. After one week incubation, the percentage of remaining soluble monomeric hIAPP in the seeded solutions was consistently less in the spiked solutions than the control hIAPP incubated solution, and less soluble hIAPP was found in the mutant ((isoD)3hIAPP) spiked solutions compared to the ((D)3hIAPP) spiked solutions (Fig. 4A) . The p-values of seeding 5% and 10% mutant ((D)3hIAPP) into the solution were higher than 0.05, which indicated the differences between the seeded solutions and the control sample were not significant. The p-values of the remaining seeded solutions were less than 0.05, which showed significant differences between the control and the seeded solutions. The normalised percentage of soluble hIAPP with 5% spiking of ((D)3hIAPP) or ((isoD)3hIAPP) was 4% and 9% less than the soluble hIAPP found in the control incubated solutions respectively. The normalised percentage of soluble hIAPP consistently decreased with increased amounts of ((D)3hIAPP) or ((isoD)3hIAPP) in the incubated solutions. For the solutions with 50% spiking of ((D)3hIAPP) or ((isoD)3hIAPP), the normalised percentage of soluble hIAPP was 28% and 46% less than the soluble hIAPP found in the control solutions respectively. These results indicate the effects of mutant hIAPPs in accelerating wild-type hIAPP are concentration-dependent. 
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Graphic Abstracts:
Deamidation sites of hIAPP were determined and the amount of fibril formed in mutant hIAPPs were higher than wild-type hIAPP. Germany). For the CAD experiments, precursor ions were first isolated using the quadrupole mass filter, then collided with argon gas and accumulated in the collision cell. The collision energy was optimized to 2-18 V and the ion accumulation time to 1-3 seconds. Fragments were then transferred to the infinity cell for detection. The most intense isotopic peak from each fragment with signal-to-noise ratio (S/N) over 5 was manually matched with the theoretical m/z. All of the fragments were internally calibrated and then assigned with an uncertainty less than 1 part-per-million (ppm).
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Experimental
Quantification of deamidated/ mutant hIAPP in solutions and fibrillary pellets.
The monoisotopic peak area of non-deamidated and deamidated/mutant hIAPP peaks were measured using Bruker DataAnalysis 4.2 software. The percentage of deamidated hIAPP (%) was calculated as follows:
The same calculation method was applied to obtain the percentage of mutant hIAPP against wild-type hIAPP.
Transmission electron microscopy (TEM).
The TEM images of the incubated solutions, including 10 µM wild-type hIAPP, 10 µM mutant ((D)3hIAPP), and 10 µM mutant ((isoD)3hIAPP) solution were acquired on a Jeol 2010F TEM operated at 200 kV. 10 µL of incubated solution was transferred onto a carbon-coated grid and settled for one minute, followed by removing the excess solution using filter paper. A 2% (w/v) uranyl acetate solution was used for the negative stain. Multiple images with magnification from x10,000 to x40,000 were acquired.
Thioflavin T (ThT) fluorescence reactivity. The fluorescence reactivity of the 10 µM hIAPP, mutant ((D)3hIAPP), mutant ((isoD)3hIAPP), and hIAPP seeding solutions were measured using a GloMax®-Multi Detection System (Promega; Wisconsin, USA).
All samples were placed in a black 96 well-plate and mixed with 10 µM ThT aqueous solution. Fluorescence spectra of the samples were acquired every 45 minutes with excitation at 405 nm and emission measurement at 490 nm, in a similar fashion to Chan et al. 34, 35 The intensities obtained from the fluorescence spectrometer were normalized to the signal intensity of the most mature fibril. Table S1 . Table S2 . Table S2 . List of the assigned fragments from the ECD MS/MS spectrum of the 7+ charge state ((isoD)3hIAPP) dimer ion. M represents one ((isoD)3hIAPP) unit. Figure S4 . The nESI-MS spectra showing the fresh, the incubated solutions, and the incubated fibrillary pellets of hIAPP mixed with 5%, 10%, 25%, or 50% of mutant ((D)3hIAPP) or ((isoD)3hIAPP).
